Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Ann Cardiol Angeiol (Paris) ; 69(3): 107-114, 2020 May.
Article in French | MEDLINE | ID: covidwho-78184

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells with angiotensin receptors, leading to pneumonia linked to COVID-19. The virus has a double impact on the cardiovascular system, the infection will be more intense if the host has cardiovascular co-morbidities and the virus can cause life-threatening cardiovascular lesions. Therapies associated with COVID-19 may have adverse cardiovascular effects. Therefore, special attention should be given to cardiovascular protection during COVID-19 infection.


Subject(s)
Betacoronavirus/pathogenicity , Cardiovascular Diseases/complications , Coronavirus Infections/complications , Pneumonia, Viral/complications , Antimalarials/adverse effects , Antimalarials/therapeutic use , Antiviral Agents/adverse effects , Antiviral Agents/therapeutic use , Azithromycin/adverse effects , Azithromycin/therapeutic use , Betacoronavirus/immunology , COVID-19 , Cardiomyopathies/virology , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Cerebrovascular Disorders/complications , Cerebrovascular Disorders/prevention & control , Cerebrovascular Disorders/virology , Chloroquine/adverse effects , Chloroquine/therapeutic use , Comorbidity , Coronary Disease/complications , Coronary Disease/prevention & control , Coronary Disease/virology , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Drug Interactions , Drug Therapy, Combination/adverse effects , Female , Humans , Hydroxychloroquine/adverse effects , Hydroxychloroquine/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Male , Methylprednisolone/adverse effects , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Risk Factors , SARS-CoV-2 , Virus Internalization/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL